Organized screening for prostate cancer does more harm than good
Prof Boniol, Research Director at the International Prevention Research Institute (iPRI) and Professor at the Strathclyde Institute for Global Public Health at iPRI, Lyon, France, will tell the congress that the total harm men experience in terms of impotence and incontinence, and the side-effects from prostate cancer treatments, severely affects their quality of life, and should further discourage the use of PSA testing for prostate cancer screening. Prof Boniol will say: "The test measures PSA protein levels, which are produced by the prostate gland, in a man’s blood, and may help detect early cancer…